Real-world dose adjustment study of first-line afatinib in pts with EGFR mutation-positive (EGFRm plus ) advanced NSCLC.
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Real-world dose adjustment study of first-line afatinib in pts with EGFR mutation-positive (EGFRm plus ) advanced NSCLC. |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Halmos B, Tan E-H, Lee MKi, Foucher P, Hsia T-C, Hochmair MJ, Griesinger F, Hida T, Kim ES, Melosky BL, Maerten A, Costa ECarcereny |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 36 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2018.36.15_suppl.e21060 |